Reported Standalone quarterly numbers for Tarsons Products are: Net Sales at Rs 80.12 crore in September 2024 up 20.81% from Rs. 66.32 crore in September 2023. Quarterly Net Profit at Rs. 12.93 crore in September 2024 up 0.98% from Rs. 12.80 crore in September 2023. EBITDA stands at Rs. 34.15 crore in September 2024 up 22.05% from Rs. 27.98 crore in September 2023.
Open FlipReported Standalone quarterly numbers for Nelcast are: Net Sales at Rs 330.42 crore in September 2024 down 7.79% from Rs. 358.34 crore in September 2023. Quarterly Net Profit at Rs. 9.82 crore in September 2024 down 41% from Rs. 16.64 crore in September 2023. EBITDA stands at Rs. 25.98 crore in September 2024 down 27.95% from Rs. 36.06 crore in September 2023.
Open FlipReported Standalone quarterly numbers for Emcure Pharmaceuticals are: Net Sales at Rs 1,104.63 crore in September 2024 up 24.4% from Rs. 887.99 crore in September 2023. Quarterly Net Profit at Rs. 86.92 crore in September 2024 up 217.98% from Rs. 27.34 crore in September 2023. EBITDA stands at Rs. 207.10 crore in September 2024 up 59.63% from Rs. 129.74 crore in September 2023.
Open Flip